Positive Phase II data for Teva/CureTech's DLBCL antibody treatment
17 May 2011
Pial Ganguli
Please Login to read the full article.
17 May 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
- 4SC achieves hat trick of resminostat successes: RCC, CRC and now Hodgkin’s
- With expert's help, Talon wins ODAC support for Marqibo
- Amgen reveals latest updated data for BiTE drug in acute lymphoblastic leukaemia
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
